Iq Consortium

Iq Consortium company information, Employees & Contact Information

Explore related pages

Related company profiles:

The International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) is a technically-focused organization of pharmaceutical and biotechnology companies with a mission of advancing science-based and scientifically-driven standards and regulations for pharmaceutical and biotechnology products worldwide. IQ provides a sustained forum for the exchange of ideas within and across technical disciplines in these industries. The Consortium is leading initiatives in the areas of chemistry, manufacturing and control; preclinical safety; drug metabolism; clinical pharmacology; quality; and the reduction, refinement, and replacement of animal testing. As part of these initiatives, which are managed by Leadership Groups and Working Groups, members lead and participate in collaborative research, industry surveys and benchmarking exercises. IQ is also partnering with governmental bodies, other trade groups, and academic researchers. Through publications, scientific conferences, workshops and roundtables, the Consortium shares the results of its work and facilitates constructive scientific exchange.

Company Details

Employees
33
Founded
-
Address
Washington, D.c., Us
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Washington, D.C.
Looking for a particular Iq Consortium employee's phone or email?

Iq Consortium Questions

News

A pharmaceutical industry survey results on the cycle time, drivers and enablers, for key deliverables in the early phase of drug product development from dose limiting toxicity to first subject first dose: The survey conducted by the IQ cycle time benchmarking w - ScienceDirect.com

A pharmaceutical industry survey results on the cycle time, drivers and enablers, for key deliverables in the early phase of drug product development from dose limiting toxicity to first subject first dose: The survey conducted by the IQ cycle time benchmarking w ScienceDirect.com

Establishing Patient-Centric Endotoxin Acceptance Criteria: An Industry Opinion - BioProcess International

Establishing Patient-Centric Endotoxin Acceptance Criteria: An Industry Opinion BioProcess International

Research and Development of Microphysiological Systems in Japan Supported by the AMED-MPS Project - Frontiers

Research and Development of Microphysiological Systems in Japan Supported by the AMED-MPS Project Frontiers

Certificate of Analysis (CoA) and Calculations for Small-Molecule Drugs - Chromatography Online

Certificate of Analysis (CoA) and Calculations for Small-Molecule Drugs Chromatography Online

Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working Group - Wiley

Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working Group Wiley

Organ-on-a-chip, a powerful new tool to improve drug testing. | Merck - Merck Group

Organ-on-a-chip, a powerful new tool to improve drug testing. | Merck Merck Group

Part 2: Designation and Justification of API Starting Materials: Current Practices across Member Companies of the IQ Consortium - ACS Publications

Part 2: Designation and Justification of API Starting Materials: Current Practices across Member Companies of the IQ Consortium ACS Publications

Part VII GMPs for Small Molecule Drugs in Early Development Workshop Summary - PharmTech

Part VII GMPs for Small Molecule Drugs in Early Development Workshop Summary PharmTech

Safety assessment of protein A and derivation of a parenteral health-based exposure limit - ScienceDirect.com

Safety assessment of protein A and derivation of a parenteral health-based exposure limit ScienceDirect.com

Clinical Significance of Therapeutic Peptide and Protein Drug Interactions: A Call to Action - Graaf - 2023 - Wiley

Clinical Significance of Therapeutic Peptide and Protein Drug Interactions: A Call to Action - Graaf - 2023 Wiley

Separation Science in Drug Development, Part IV: Quality Control - Chromatography Online

Separation Science in Drug Development, Part IV: Quality Control Chromatography Online

An IQ Consortium Perspective on Best Practices for Bioanalytical and Immunogenicity Assessment Aspects of CAR-T and TCR-T Cellular Therapies Development - Wiley

An IQ Consortium Perspective on Best Practices for Bioanalytical and Immunogenicity Assessment Aspects of CAR-T and TCR-T Cellular Therapies Development Wiley

Immunogenicity assessment of AAV-based gene therapies: An IQ consortium industry white paper - ScienceDirect.com

Immunogenicity assessment of AAV-based gene therapies: An IQ consortium industry white paper ScienceDirect.com

Artificial Intelligence for Quantitative Modeling in Drug Discovery and Development: An Innovation and Quality Consortium Perspective on Use Cases and Best Practices - Wiley

Artificial Intelligence for Quantitative Modeling in Drug Discovery and Development: An Innovation and Quality Consortium Perspective on Use Cases and Best Practices Wiley

Translational pharmacokinetic-pharmacodynamic analysis in the pharmaceutical industry: an IQ Consortium PK-PD Discussion Group perspective - ScienceDirect.com

Translational pharmacokinetic-pharmacodynamic analysis in the pharmaceutical industry: an IQ Consortium PK-PD Discussion Group perspective ScienceDirect.com

Top Iq Consortium Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant